JPRN-UMIN000004945已完成1 期
Cancer peptide vaccine therapy for patients with advanced metastatic colorectal cancer. Phase I/II clinical trial. - Cancer peptide vaccine for advanced metastatic colorectal cancer.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Cardiac diseases necessitating treatments 2 Myocardial infarction less than 6 months 3 Expectant or possible expectant women During lactation 4 Active infectious diseases 5 Systemic use of steroid hormones or immunosuppressive drugs 6 Allergy to peptides or IFA 7 Others (Doctors judges)
研究者
相似试验
已完成
1 期
Treatment with cancer peptide vaccine cocktail derived from URLC10, KIF20A, VEGFR-1 and VEGFR-2 for the patients with advanced or recurrent esophageal cancer refractory to the standerd tharapyEsophageal cancerJPRN-UMIN000013709Wakayama Medical University40
招募中
1 期
A clinical study of cancer peptides vaccine therapy using URLC10, CDCA1, and KOC1-targeted peptides in the patients who had no more treatment against oral canceroral cancerJPRN-UMIN000008379Department of Oral and Maxillofacial surgery, Graduated school of medicine Kumamoto University40
招募中
1 期
A clinical study of cancer peptides vaccine therapy in the patients who have recieved surgical resection and had no residual tumor for head and neck cancerhead and neck cancerJPRN-UMIN000008380Department of Oral and Maxillofacial surgery, Graduated school of medicine Kumamoto University50
尚未招募
2 期
WT1 peptide-based cancer vaccine in patients with high risk rhabdomyosarcoma, a multicenter, phase 2 clinical studyrhabdomyosarcomaJPRN-UMIN000013325Osaka university graduate school of medicine Pediatrics33
已完成
1 期
Cancer Vaccine Therapy using Epitope Peptide Restricted to HLA-A*02 (URLC10) in Patients with Non-small Cell Lung Cancer Refractory to Standard Therapy (Phase I study)on-small Cell Lung CancerJPRN-UMIN000003190Shiga University of Medical Science9